Bone resorption and incretin hormones following glucose ingestion in healthy emerging adults.
健康新成年人攝取葡萄糖後的骨質吸收和胰高血糖素激素。
J Clin Transl Endocrinol 2023-05-09
Gut hormone analogues and skeletal health in diabetes and obesity: Evidence from preclinical models.
糖尿病和肥胖症中腸道激素類似物對骨骼健康的影響:來自預臨床模型的證據。
Peptides 2024-04-25
Effect of gut hormones on bone metabolism and their possible mechanisms in the treatment of osteoporosis.
腸道激素對骨代謝的影響及其在骨質疏鬆症治療中的可能機制。
Front Pharmacol 2024-05-11
Role of LRP5/6/GSK-3β/β-catenin in the differences in exenatide- and insulin-promoted T2D osteogenesis and osteomodulation.
LRP5/6/GSK-3β/β-catenin 在 exenatide 和胰島素促進的 T2D 骨生成和骨調控差異中的作用。
Br J Pharmacol 2024-05-28
Glucagon-like Peptide-1 Receptor Agonists and Diabetic Osteopathy: Another Positive Effect of Incretines? A 12 Months Longitudinal Study.
胰高血糖素樣肽-1受體激動劑與糖尿病性骨病:胰高血糖素樣激素的另一個正面效應?一項為期12個月的縱向研究。
Calcif Tissue Int 2024-06-12
The multiple actions of dipeptidyl peptidase 4 (DPP-4) and its pharmacological inhibition on bone metabolism: a review.
二肽基肽酶 4 (DPP-4) 的多重作用及其對骨代謝的藥理抑制:一篇綜述。
Diabetol Metab Syndr 2024-07-25
Impact of Different Anti-Hyperglycaemic Treatments on Bone Turnover Markers and Bone Mineral Density in Type 2 Diabetes Mellitus Patients: A Systematic Review and Meta-Analysis.
不同抗高血糖治療對2型糖尿病患者骨代謝標記和骨密度的影響:系統性回顧與Meta分析。
Int J Mol Sci 2024-07-27